A new era in HIV treatment: the entry inhibitors.
Berger
Daniel S
DS
D065100:CCR5 Receptor Antagonists; D017322:Clinical Trials, Phase II as Topic; D023581:HIV Fusion Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans
D065100:CCR5 Receptor Antagonists; D023581:HIV Fusion Inhibitors